José M. Mascaró - Concepedia

Author

José M. Mascaró

Also Known As

J M MASCARO, J M Mascaro, J M Mascaró, J M Mascaró-Galy, J MASCARO, J Mascaro, J Mascaró, J-M Mascaró Jr, J. M. MASCARO, J. M. MASCARÓ

500

Publications

9.2K

Citations

H-Index

126

Concepts

All Affiliations

Universitat de Barcelona Hospital Clínic de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Medical College of Wisconsin University of Groningen

About

José M. Mascaró is an author at Universitat de Barcelona specializing in medicine, dermatology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	52	2.6K
2	Public Health	3	3	412
3	Natural Sciences	2	2	204
4	Engineering	1	1	16
5	Health Sciences	1	2	48

José M. Mascaró

120

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts Dédée F. Murrell, Benjamin S. Daniel, P. Joly, Journal of the American Academy of Dermatology Bullous PemphigoidPublic HealthInternational PanelOutcome MeasuresEpidemiology	2011	365
Diagnosis and management of pemphigus: Recommendations of an international panel of experts Dédée F. Murrell, S.M. Peña, P. Joly, Journal of the American Academy of Dermatology MedicineDermatologyPathologyInternational Panel	2018	356
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) P. Joly, Barbara Horváth, Soner Uzun, Journal of the European Academy of Dermatology and Venereology	2020	319
Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition Joan Albanell, Federico Rojo, Steve Averbuch, Journal of Clinical Oncology	2002	253
Mucosal and Mucocutaneous (Generalized) Pemphigus Vulgaris Show Distinct Autoantibody Profiles Xiang Ding, Valéria Aoki, José M. Mascaró, Journal of Investigative Dermatology MedicinePathologyDermatology	1997	244
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>) Luca Borradori, Nina van Beek, Claudio Feliciani, Journal of the European Academy of Dermatology and Venereology	2022	225
A Highly Sensitive Enzyme-Linked Immunosorbent Assay for the Detection of Circulating Anti-BP180 Autoantibodies in Patients with Bullous Pemphigoid Detlef Zillikens, José M. Mascaró, Pamela A. Rose, Journal of Investigative Dermatology Autoimmune DiseaseAutoantibody ProductionMedicineImmunologySerologic Testing	1997	224
Roaccutane Treatment Guidelines: Results of an International Survey W.J. Cunliffe, P.C.M. van de Kerkhof, R. Caputo, Dermatology	1997	198
Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. Begoña Mellado, Dolors Colomer, T Castel, Journal of Clinical Oncology	1996	185
Paraneoplastic pemphigus in children and adolescents Daniel Mimouni, Grant J. Anhalt, Zelmira Lazarova, British Journal of Dermatology	2002	178

Page 1